Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail
about
Laboratory Investigations of African Pouched Rats (Cricetomys gambianus) as a Potential Reservoir Host Species for Monkeypox VirusThe yeast inositol polyphosphate 5-phosphatase Inp54p localizes to the endoplasmic reticulum via a C-terminal hydrophobic anchoring tail: regulation of secretion from the endoplasmic reticulum.Phospholipase DVisualization of intracellular movement of vaccinia virus virions containing a green fluorescent protein-B5R membrane protein chimera.Virulence in murine model shows the existence of two distinct populations of Brazilian Vaccinia virus strains.Vaccinia virus nonstructural protein encoded by the A11R gene is required for formation of the virion membrane.Effects of deletion or stringent repression of the H3L envelope gene on vaccinia virus replication.Repression of vaccinia virus Holliday junction resolvase inhibits processing of viral DNA into unit-length genomes.Cellular membrane-binding ability of the C-terminal cytoplasmic domain of human immunodeficiency virus type 1 envelope transmembrane protein gp41.Vaccinia virus intracellular movement is associated with microtubules and independent of actin tailsAttenuation of vaccinia virus by the expression of human Flt3 ligandInduction of Noxa-mediated apoptosis by modified vaccinia virus Ankara depends on viral recognition by cytosolic helicases, leading to IRF-3/IFN-β-dependent induction of pro-apoptotic Noxa.Simultaneous high-resolution analysis of vaccinia virus and host cell transcriptomes by deep RNA sequencingVaccinia virus H3L envelope protein is a major target of neutralizing antibodies in humans and elicits protection against lethal challenge in mice.Vaccinia virus J1R protein: a viral membrane protein that is essential for virion morphogenesis.Vaccinia virus proteome: identification of proteins in vaccinia virus intracellular mature virion particles.Identification of vaccinia virus epitope-specific HLA-A*0201-restricted T cells and comparative analysis of smallpox vaccines.Evidence for an essential catalytic role of the F10 protein kinase in vaccinia virus morphogenesis.Vaccinia virus G7L protein Interacts with the A30L protein and is required for association of viral membranes with dense viroplasm to form immature virions.Mapping and functional analysis of interaction sites within the cytoplasmic domains of the vaccinia virus A33R and A36R envelope proteinsVaccinia virus G9 protein is an essential component of the poxvirus entry-fusion complex.Redistribution of cyclophilin A to viral factories during vaccinia virus infection and its incorporation into mature particlesInvestigation of structural and functional motifs within the vaccinia virus A14 phosphoprotein, an essential component of the virion membrane.Existence of an operative pathway from the endoplasmic reticulum to the immature poxvirus membrane.Measurement of antibody responses to Modified Vaccinia virus Ankara (MVA) and Dryvax(®) using proteome microarrays and development of recombinant protein ELISAsIsolation and Characterization of Monoclonal Antibodies Against a Virion Core Protein of Orf Virus Strain NA1/11 As Potential Diagnostic Tool for Orf VirusesPoxvirus DNA topoisomerase knockout mutant exhibits decreased infectivity associated with reduced early transcription.Correlation of immunogenicities and in vitro expression levels of recombinant modified vaccinia virus Ankara HIV vaccines.Analysis of viral membranes formed in cells infected by a vaccinia virus L2-deletion mutant suggests their origin from the endoplasmic reticulum.Vaccinia virus morphogenesis: a13 phosphoprotein is required for assembly of mature virions.Synthesis and function of membrane phosphoinositides in budding yeast, Saccharomyces cerevisiaeVaccinia virus l1 protein is required for cell entry and membrane fusion.The Vaccinia Virus H3 Envelope Protein, a Major Target of Neutralizing Antibodies, Exhibits a Glycosyltransferase Fold and Binds UDP-GlucoseVaccinia virus WR53.5/F14.5 protein is a new component of intracellular mature virus and is important for calcium-independent cell adhesion and vaccinia virus virulence in miceAssociation of the vaccinia virus A11 protein with the endoplasmic reticulum and crescent precursors of immature virions.Orthopoxvirus targets for the development of new antiviral agents.Assembly and disassembly of the capsid-like external scaffold of immature virions during vaccinia virus morphogenesis.Vaccinia virus mutants with alanine substitutions in the conserved G5R gene fail to initiate morphogenesis at the nonpermissive temperature.Deletion of the Vaccinia Virus I2 Protein Interrupts Virion Morphogenesis, Leading to Retention of the Scaffold Protein and Mislocalization of Membrane-Associated Entry Proteins.Identification and characterization of three immunodominant structural proteins of fowlpox virus.
P2860
Q27304222-209F38B5-FCEE-42BE-BA4A-AF2C28FE33BBQ27940135-9F302634-D9DA-43A3-BF16-8E71F483A814Q28253553-8FBB8008-F1C6-4F05-B895-B7BA76EE8024Q31905797-999F42E8-4963-46C3-9E28-BBD7C842B43AQ33363146-45ECA098-8286-45B4-AF86-070949854675Q33788819-02B93DA6-14FC-4E39-B44C-E06E184E9797Q33809822-2BBE8B6E-28BB-41D6-AA66-B26D4F593335Q33843207-20DAD5C9-6325-4F97-BF23-A7318B3AE765Q33847059-4641AF0E-159E-4F1F-9513-F782771576E3Q33849999-7A87F064-018A-409C-8326-1B6481940A05Q33907236-6073DA23-C238-4091-98D6-7D196E394F82Q33941041-391DE28A-0AC7-4B3B-83F8-014C40FC6045Q33953053-31D85A65-7D22-499F-9BA2-9A060C037269Q33987410-2E13F904-6EAD-422B-8EBA-7E0E1613681AQ34347131-C67F4E16-6973-4B21-97F2-1AFAF34C32F1Q34434835-E2556760-3603-4A0D-8B15-9A652641895EQ34467405-F92686CF-B5E8-4F59-A34F-04B64C31912AQ34553748-D9F8CC75-B60D-487C-AFB5-38B4FF33B1C6Q34745104-A4D5A6CC-88FA-430C-9B0F-8D4757DB5DA8Q34781856-FE239481-492D-4F0E-AA62-5300272372ABQ35101454-53360563-44F9-4D6A-BA90-7B8BEAF7759BQ35182206-F254B759-20FD-4724-A4D4-9A4066EA8B52Q35182365-26304CA1-7DA3-47F7-A550-F1AAA49FFC5EQ35193307-6500F358-8603-495D-9C10-FA649DC2BA48Q35634159-5F8CD482-7AE5-486B-8359-8BD8F9E9D86FQ36015315-B8179B5D-199A-42D7-8B51-4BC45284AA5CQ36160688-76DF5364-3DAB-4892-945C-34669615EECCQ36488676-FB964BB8-4D72-4A77-B99F-BC8123239BF7Q36559826-62672881-729B-48D5-B25E-4AEE9B943694Q36684413-D150E3DD-6AD6-4879-9CD5-2C5B8A4A554EQ36768641-A234DB60-ED65-4D57-9FE2-D024A76918D3Q36845831-5D8A067A-D99D-4170-A92F-E3C619C6ED8BQ36878858-9514D33F-31AF-4C66-85BD-61F8466510D3Q36933959-38E004DC-7D42-4BCF-9D7F-F64E2F6C879CQ37123182-C7B7F954-E104-416D-BF25-CDC739EE0DB6Q37173398-901F2690-5261-4A34-87CE-4AD5AB40F187Q37333931-BF558940-D9BE-47E1-82CD-5CA3782AD72FQ37511614-C10687F2-0819-4A2B-BCEC-E41A40580D7BQ38704031-DC323230-A0EA-47D1-BDFF-A48D7339F17AQ39684877-6BC11175-EFD2-4EDF-975D-1E08B0B20140
P2860
Characterization of the vaccinia virus H3L envelope protein: topology and posttranslational membrane insertion via the C-terminal hydrophobic tail
description
2000 nî lūn-bûn
@nan
2000 թուականի Օգոստոսին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի օգոստոսին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@ast
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@en
type
label
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@ast
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@en
prefLabel
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@ast
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@en
P2093
P2860
P1433
P1476
Characterization of the vaccin ...... he C-terminal hydrophobic tail
@en
P2093
A Weisberg
E J Wolffe
F G da Fonseca
P2860
P304
P356
10.1128/JVI.74.16.7508-7517.2000
P577
2000-08-01T00:00:00Z